What is the market price of adavosertib targeted drug?
Adavosertib is a targeted drug mainly used to treat cancers with specific mutations, especially some high-risk tumor types, such as ovarian cancer and colorectal cancer. The drug blocks the repair mechanism of cancer cells by inhibiting the ATR (ATM and Rad3 related kinase) pathways, making the cancer cells unable to repair their DNA damage, eventually leading to their death. Although adagrasib has achieved certain efficacy in foreign clinical trials, the drug has not yet been launched in the Chinese market.
Since adagrasib has not yet been approved domestically, patients cannot purchase the drug directly in China and can only obtain it through foreign channels. The American version of the original drug Adagrasibu is extremely expensive, with a box usually selling for more than 100,000 yuan, which is very expensive. This price puts many patients under greater financial pressure, especially when long-term treatment is required. The price of the original drug may become a major obstacle to treatment.
Compared with the American version of the original drug, generic drugs produced in Laos have significant price advantages. Each box of generic drugs in Laos costs about more than 3,000 yuan, which is much cheaper than the original drugs. Although they are cheaper, the ingredients of Lao generic drugs are basically the same as the original drugs and can provide similar efficacy and safety. This allows some patients with limited financial conditions to reduce the cost of treatment by choosing generic drugs and enjoy similar therapeutic effects to the original drugs.
It should be noted that when patients choose to purchase generic adagrasiib, they should ensure that they purchase it through formal channels to ensure drug quality and safety. Since the manufacturers and quality standards of generic drugs may be different, it is best for patients to purchase and use them under the advice and guidance of their doctors. Overall, although the original drug of adagrasiib is expensive, overseas generic drugs provide a more affordable treatment option for patients in need of such targeted therapy.
References:https://www.krazati.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)